Literature DB >> 3384192

Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat.

I Sussman1, F M Matschinsky.   

Abstract

ATP, ADP, phosphocreatine (PCr), creatine (Cr), glucose, malate, sorbitol, and myo-inositol (MI) were measured by quantitative histochemical techniques in pure neuroectodermal tissue of rat embryos of gestation days 11 and 12 that were dissected from normal and streptozocin-induced diabetic mothers. Neither gestational age nor maternal diabetes affected the tissue's energy potential (ATP-to-ADP and PCr-to-Cr ratios). Diabetes resulted in a fourfold rise in the embryonic glucose and a 25% increase in neuroectodermal malate content. Maternal hyperglycemia caused a rise in fetal sorbitol at days 11 and 12 of gestation. The MI content of the neuroectoderm was not affected by the maternal diabetic state in perfusion embryos (day 11); however, the near doubling of MI that occurs from day 11 to day 12 during normal development was prevented. Thus, embryos isolated from diabetic mothers on gestation day 12 had 30% less MI than embryos isolated from normal mothers. From these data we conclude that a rise in tissue sorbitol is not always accompanied by a fall in tissue MI. These results and recent information in the literature implicate involvement of decreased MI concentrations in the process leading to malformation of the nervous system in diabetic embryopathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384192     DOI: 10.2337/diab.37.7.974

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

Review 1.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Diabetic embryopathy: a developmental perspective from fertilization to adulthood.

Authors:  M Castori
Journal:  Mol Syndromol       Date:  2013-02

3.  High glucose concentration inhibits migration of rat cranial neural crest cells in vitro.

Authors:  N Suzuki; K Svensson; U J Eriksson
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos.

Authors:  L Baker; R Piddington; A Goldman; J Egler; J Moehring
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

Review 5.  Understanding diabetic teratogenesis: where are we now and where are we going?

Authors:  Sheller Zabihi; Mary R Loeken
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

6.  Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation.

Authors:  M Hashimoto; S Akazawa; M Akazawa; M Akashi; H Yamamoto; Y Maeda; Y Yamaguchi; H Yamasaki; D Tahara; T Nakanishi
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

7.  Glucose transporter gene expression in rat conceptus during high glucose culture.

Authors:  Y Takao; S Akazawa; K Matsumoto; H Takino; M Akazawa; R A Trocino; Y Maeda; S Okuno; E Kawasaki; S Uotani
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

8.  Chronic exposure to high glucose decreases myo-inositol in cultured cerebral microvascular pericytes but not in endothelium.

Authors:  I Sussman; M P Carson; V Schultz; X P Wu; A L McCall; N B Ruderman; K Tornheim
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

9.  Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro.

Authors:  U J Eriksson; L A Borg
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

10.  Maternal diabetes alters transcriptional programs in the developing embryo.

Authors:  Gabriela Pavlinkova; J Michael Salbaum; Claudia Kappen
Journal:  BMC Genomics       Date:  2009-06-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.